SAN DIEGO, May 17, 2021 /PRNewswire/ -- Inhibrx, Inc.
(NASDAQ: INBX), a clinical-stage biotechnology company focused on
developing a broad pipeline of novel biologic therapeutic
candidates, announced today that the Company will be presenting at
the following upcoming virtual investor conferences:
- Jefferies Healthcare Conference; Wednesday, June 2nd at 12:30 p.m. Pacific Time
- JMP Securities Life Sciences Conference; Thursday, June 17th at 8:00 a.m. Pacific Time
The investor conference presentations will be webcast live and
may be accessed through a link on the investors section of
Inhibrx's website at
https://inhibrx.investorroom.com/events-and-presentations. The
webcasts will be available for 60 days following the event.
About Inhibrx, Inc.
Inhibrx is a clinical-stage
biotechnology company focused on developing a broad pipeline of
novel biologic therapeutic candidates in oncology and orphan
diseases. Inhibrx utilizes diverse methods of protein engineering
to address the specific requirements of complex target and disease
biology, including its proprietary sdAb platform. Inhibrx has
collaborations with bluebird bio, Bristol-Myers Squibb and Chiesi.
For more information, please visit www.inhibrx.com.
Investor and Media Contact:
Amy Conrad
Juniper Point
amy@juniper-point.com
858-366-3243
View original content to download
multimedia:http://www.prnewswire.com/news-releases/inhibrx-announces-participation-in-upcoming-investor-conferences-301291482.html
SOURCE Inhibrx, Inc.